Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ido Tzanani"'
Publikováno v:
Acta Dermato-Venereologica, Vol 103 (2023)
Current research on the malignancy rate and spectrum of malignancies in patients with bullous pemphigoid is contradictory. The aims of this study were to determine the prevalence and spectrum of malignancy in patients with bullous pemphigoid and to c
Externí odkaz:
https://doaj.org/article/fd8e9e82bed4484db2a76faccf383f9a
Autor:
Eran Galili, Shir Rubinstein Levy, Ido Tzanani, Oz Segal, Anna Lyakhovitsky, Aviv Barzilai, Sharon Baum
Publikováno v:
Dermatology. 239:188-194
Background: Guttate psoriasis (GP), a distinct variant of psoriasis, is more common in children and adolescents. The long-term course of these patients has sparsely been examined, with few studies reporting the rates of relapse, persistence, and furt
Autor:
Anna Lyakhovitsky, Ido Tzanani, Sarit Gilboa, Oz Segal, Eran Galili, Sharon Baum, Aviv Barzilai
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 37:184-193
Hair- and scalp-related disorders (HSRDs) encompass a wide range of conditions that affect people of all ages.To evaluate the workload and trends in HSRDs at an outpatient dermatological clinic in a tertiary medical centre over a 10-year period.Medic
Autor:
Ido Tzanani, Inbar Tzachy-Suissa, Aviv Barzilai, Felix Pavlotsky, Anna Lyakhovitsky, Sharon Baum
Publikováno v:
Clinical and Experimental Dermatology.
Background Dipeptidyl peptidase-4 inhibitors (DPP4is), drugs used to treat type 2 diabetes mellitus (DM2), show a significant association with bullous pemphigoid (BP) development. Objectives To evaluate the clinical course and development of BP among
Publikováno v:
The Israel Medical Association journal : IMAJ. 24(8)
Diabetes mellitus (DM) is one of the risk factors for progression from latent to active tuberculosis. However, the effect of DM on subsequent tuberculosis treatment is still inconclusive.To compare tuberculosis treatment outcomes and the rate of drug